Modelling the association between adherence and viral load in HIV-infected patients

Statistics in Medicine

Volumn 24, Issue 17, 2005, Pages 2719-2731

  Vrijens, Bernard ^a,b,f   Goetghebeur, Els ^a,c   de Klerk, Erik ^b   Rode, Richard ^d   Mayer, Steve ^d   Urquhart, John ^b,e  

^a GHENT UNIVERSITY   (Belgium)

^b AARDEX Group   (Switzerland)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d ABBOTT LABORATORIES   (United States)

^e MAASTRICHT UNIVERSITY   (Netherlands)

^f AARDEX Ltd   (Belgium)

Author keywords

Adherence; Compliance; Continuation ratio model; HIV; Internal exposure; Medication event monitoring system (MEMS); Repeated longitudinal ordinal responses

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; VIRUS RNA;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EXPOSURE; DRUG MONITORING; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MATHEMATICAL MODEL; MULTICENTER STUDY; MULTIPLE DRUG DOSE; PATIENT COMPLIANCE; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE; TREATMENT OUTCOME; VIRUS LOAD;

FEMALE; HIV; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; LONGITUDINAL STUDIES; MODELS, STATISTICAL; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIALS; RNA, VIRAL; VIRAL LOAD;

EID: 24944436366     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.2130     Document Type: Article

References (15)

1. Mellors JW, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272:1167-1170.
2. Hughes MD, Johnson VA, Hirsch MS, Bremer JW, Elbeik T, Erice A, Kuritzkes DR, Scott WA, Spector SA, Basgoz N, Fischl MA, D'Aquila RT. ACTG 241 protocol virology substudy team monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. Annals of Internal Medicine 1997; 126:929-938.
3. Marschner IC, Collier AC, Coombs RW, D'Aquila RT, DeGruttola V, Fischl MA, Hammer SM, Hughes MD, Johnson VA, Katzenstein DA, Richman DD, Smeaton LM, Spector SA, Saag MS. Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy. Journal of Infectious Diseases 1998; 177:40-47.
4. Delta Coordinating Committee and Delta Virology Committee. HIV-1 RNA response to antiretroviral treatment in 1280 participants in the delta trial: an extended virology study. AIDS 1999; 13:57-65.
5. Montaner JS, Hogg R, Raboud J, Harrigan R, O'Shaughnessy M. Antiretroviral treatment in 1998. The Lancet 1998; 352:1919-1922.
6. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squler C, Wagener MM, Singh N. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Journal of Internal Medicine 2000; 133:21-30.
7. Hughes MD. Analysis and design issues for studies using censored biomarkers measurements with an example of viral load measurements in HIV clinical trials. Statistics in Medicine 2000; 19:3171-3191.
8. Ruiz L, Carcelain G, Martinez-Picado J, Frost S, Marfil S, Paredes R, Romeu J, Ferrer E, Morales-Lopetegi K, Autran B, Clotet B. HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection. AIDS 2001; 15(9):F19-F27.
9. Vrijens B, Goetghebeur E. Comparing compliance patterns between randomized treatments. Controlled Clinical Trials 1997; 18:187-203.
10. Vrijens B, Tousset E, Rode R, Bertz R, Mayer SL. Within-patient variance reduced in an ARV PI study by switching from patient-reported to electronically monitored dosing times. Second IAS Conference on HIV Pathogenesis and Treatment, Paris, France, July 2003, Poster number 846, 2003.
11. Agresti A. Categorical Data Analysis. Wiley: New York, 1990.
12. Dos Santos DM, Berridge DM. A continuation ratio random effect model for repeated ordinal responses. Statistics in Medicine 2000; 19:3377-3388.
13. Lindsey JK, Jones B, Ebbutt AF. Simple models for repeated ordinal responses with an application to a seasonal rhinitis clinical trial. Statistics in Medicine 1997; 16:2873-2882.
14. Box GEP, Cox DR. An analysis of transformations. Journal of the Royal Statistical Society B 1964; 26: 211-243.
15. Vrijens B, Goetghebeur E. Electronic monitoring of variation in drug intakes can reduce bias and improve precision on pharmacokinetic/pharmacodynamic population studies. Statistics in Medicine 2004; 23:531-544.